Exact Mass: 438.050627
Exact Mass Matches: 438.050627
Found 106 metabolites which its exact mass value is equals to given mass value 438.050627,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Riboflavin cyclic-4',5'-phosphate
Riboflavin cyclic-4,5-phosphate, also known as cfmn or cyclic flavin mononucleotide, is a member of the class of compounds known as flavins. Flavins are compounds containing a flavin (7,8-dimethyl-benzo[g]pteridine-2,4-dione) moiety, with a structure characterized by an isoalloaxzine tricyclic ring. Riboflavin cyclic-4,5-phosphate is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Riboflavin cyclic-4,5-phosphate can be found in a number of food items such as sea-buckthornberry, horseradish tree, malabar spinach, and wild rice, which makes riboflavin cyclic-4,5-phosphate a potential biomarker for the consumption of these food products. Riboflavin cyclic-4,5-phosphate is part of the Glycerolipid metabolism, and RIG-I-like receptor signaling pathway pathways. It is a substrate for: Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing).
5-(2,4-Dioxo-thiazolidin-5-ylmethyl)-2-methoxy-N-(4-trifluoromethyl-benzyl)-benzamide(KRP297)
C20H17F3N2O4S (438.08610780000004)
Hexanitrohexaazaisowurtzitane
5-((2,4-Dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide
C20H17F3N2O4S (438.08610780000004)
Remimazolam
N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
8-Glucuronoyl-xanthurensaeure-N-carboxymethylamid
C18H18N2O11 (438.09105580000005)
1,3,6,7-tetrahydroxyxanthone-4-beta-D-glucopyranoside|isomangiferin
(4aS,5R,6S)-5-ethenyl-6-(beta-D-glucopyranosyloxy)-4,4a,5,6-tetrahydro-1-oxo-1H,3H-pyrano[3,4-c]pyran-3-sulfonic acid
C16H22O12S (438.08319320000004)
(2S,3R)-3,10-dihydroxy-9-O-(6-hydroxy-7-O-methyl-2-hydroxymethyldihydrobenzofuran-3-yl)dibenz--pyran-6-one
5-Amino-imidazol-carbonsaeure-(4)-succinylamid-ribotid|N-[5-amino-1-(O5-phosphono-beta-6D-ribofuranosyl)-1H-imidazole-4-carbonyl]-succinamic acid
7-Carboxynalidixic acid glucuronide
C18H18N2O11 (438.09105580000005)
3-[(3,3,4,4,5,5,6,6,7,7,8,8,8-TRIDECAFLUOROOCTYL)OXY]-1,2-PROPANEDIOL
C11H11F13O3 (438.05005719999997)
3-[[4,5-Dihydro-3-methyl-5-oxo-1-(4-sulfophenyl)-1H-pyrazol-4-yl]azo]benzenesulfonic acid
n-(8-maleimidocapryloxy)sulfosuccinimide, sodium salt
C16H19N2NaO9S (438.07089240000005)
5-(2,4-difluorophenyl)-2-hydroxy-N-[4-nitro-3-(trifluoromethyl)phenyl]benzamide
1,1-(BUTANE-1,4-DIYL)BIS[4-AZA-1-AZONIABICYCLO[2.2.2]OCTANE] DIBROMIDE
Florpyrauxifen-benzyl
C20H14Cl2F2N2O3 (438.03494980000005)
4-[3-(2-Chloro-4,5-Difluoro-Benzoyl)ureido]-3-Trifluoromethoxybenzoic Acid
5-{3-[3-(2,4-Dichloro-benzoyl)-ureido]-2-methyl-phenoxy}-pentanoic acid
4-{4-[3-(2,4-Dichloro-benzoyl)-ureido]-2,3-dimethyl-phenoxy}-butyric acid
CNS-7056
N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
10-[(2R,3R)-2,3-dihydroxy-3-[(4S)-2-hydroxy-2-oxo-1,3,2lambda5-dioxaphospholan-4-yl]propyl]-7,8-dimethylbenzo[g]pteridine-2,4-dione
(E)-2-hydroxy-1-[4,5,7,10-tetrahydroxy-3-(3-oxobutanoyl)anthracen-2-yl]pent-2-ene-1,4-dione
3-[4-[(4,6-Dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)methyl]-3-(2-oxo-1-benzopyran-3-yl)-1-pyrazolyl]propanoic acid
C20H14N4O6S (438.06340240000003)
2-Benzo[1,3]dioxol-5-yl-7-(4-chloro-benzyloxy)-3,5-dihydroxy-chromen-4-one
1-S-[4-(methylsulfonyl)-N-(sulfonatooxy)butanimidoyl]-1-thio-beta-D-glucopyranose
2-[[4-amino-5-[4-(difluoromethoxy)phenyl]-1,2,4-triazol-3-yl]thio]-N-[(2-furanylmethylamino)-oxomethyl]acetamide
3-chloranyl-N-[3-[[[(E)-(3-nitro-6-oxidanylidene-cyclohexa-2,4-dien-1-ylidene)methyl]amino]carbamoyl]phenyl]benzamide
C21H15ClN4O5 (438.07309300000003)
1-[[1-[(3-Chlorophenyl)methyl]-2-oxo-3-indolylidene]amino]-3-(2-fluorophenyl)thiourea
2-(3-oxo-4H-1,4-benzothiazin-2-yl)acetic acid (7-acetamido-2-oxo-1-benzopyran-4-yl)methyl ester
2-[(5-cyano-4-oxo-6-phenyl-1H-pyrimidin-2-yl)thio]-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]acetamide
C16H9F3N6O2S2 (438.01804899999996)
N-[(6-chloro-2-oxo-4-phenyl-1H-quinolin-3-yl)methyl]-4-methylbenzenesulfonamide
C23H19ClN2O3S (438.08048540000004)
1-(4-Bromophenyl)sulfonyl-4-[(3-methoxyphenyl)methyl]-1,4-diazepane
N-[5-[2-(2,4-dichloroanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]-4-pentenamide
C18H16Cl2N4OS2 (438.01425459999996)
(3aR,4S,9aR,9bS)-N-(4-chlorophenyl)-2-(4-fluorophenyl)-1,3-dioxo-3a,4,9a,9b-tetrahydropyrrolo[1,2]pyrrolo[3,5-b]pyridazine-4-carboxamide
N-(4-chlorophenethyl)-2-(5-oxo-2,3-dihydrothiazolo[3,2:1,2]pyrimido[5,4-b]indol-6(5H)-yl)acetamide
C22H19ClN4O2S (438.09171840000005)
4-[(E)-N-[(3,5-Dichloropyridin-2-yl)amino]-C-methylcarbonimidoyl]-N-(furan-2-ylmethyl)benzenesulfonamide
C18H16Cl2N4O3S (438.03201260000003)
(4,8-Dihydroxy-17-methoxy-10-oxo-2-oxatricyclo[13.2.2.13,7]icosa-1(17),3,5,7(20),15,18-hexaen-14-yl) hydrogen sulate
7-Chloro-2-(1-hydroxy-3-methoxy-4-oxocyclohexa-2,5-dien-1-yl)-3,5,6,8-tetramethoxychromen-4-one
C20H19ClO9 (438.07175540000003)
3-[4-[(E)-3-(4-Bromophenyl)-3-oxoprop-1-enyl]-3-(4-methylphenyl)pyrazol-1-yl]propanoic acid
(2R)-2-hydroxy-3,3-dimethyl-1-oxo-1-[[3-oxo-3-(2-sulfosulfanylethylamino)propyl]amino]-4-phosphonooxybutane
riboflavin cyclic 4,5-phosphate
A flavin mononucleotide that is riboflavin (vitamin B2) in which the 4 and 5 hydroxy groups have been converted into a cyclic hydrogen phosphate ester.
glucolimnanthin(1-)
An aralkylglucosinolate that is glucotropeolin in which the phenyl group is substituted at position 3 by a methoxy group.
BMT-145027
C23H14ClF3N4 (438.08590300000003)
BMT-145027 is an mGluR5 positive allosteric modulator without inherent agonist activity, exhibits an EC50 of 47 nM.
VU 6008667
C24H17ClF2N2O2 (438.09465559999995)
VU 6008667 is a selective negative allosteric modulator of M5 NAM with IC50s of 1.2 μM and 1.6 μM for human M5 and rat M5, respectively. High CNS penetration[1].
{4-[(1s,3ar,4s,6ar)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenyl}oxidanesulfonic acid
3,10-dihydroxy-9-{[6-hydroxy-2-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-3-yl]oxy}benzo[c]chromen-6-one
(6s)-16-chloro-4,21-dihydroxy-15-methoxy-6,17-dimethyl-7-oxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-1(21),3,5(9),10,13,15,17,19-octaene-2,8,12-trione
methyl 3-(3,4-dihydroxyphenyl)-2-{6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}prop-2-enoate
13,14-dihydroxy-3-(4-hydroxyphenyl)-7-phenyl-5,10-dioxatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁶]hexadeca-1(9),2,6,11,13,15-hexaene-4,8-dione
methyl 2',6-dihydroxy-5'-(3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl)-[1,1'-biphenyl]-3-carboxylate
2-(3,5-dichloro-2-hydroxy-6-methoxy-4-methylbenzoyl)-4,6-dihydroxy-3-(3-methylbut-2-en-1-yl)benzaldehyde
(2r,3s)-7,9-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4,5-trioxatetraphen-10-one
1,3,6,7-tetrahydroxy-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
2,3,6,7-tetrahydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
methyl 2',6-dihydroxy-5'-[(2s,3s)-3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-[1,1'-biphenyl]-3-carboxylate
(1r,4s,5r,6r,7s,9r,11r,14s,15r,16r,19r)-5,6,15-trihydroxy-21,22-dithia-3,13-diazaheptacyclo[14.4.1.1⁷,¹¹.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone
3-({5-amino-1-[(2r,3r,4r,5s)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]imidazole-4-carbonyl}-c-hydroxycarbonimidoyl)propanoic acid
7,9-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4,5-trioxatetraphen-10-one
3-[(5-amino-1-{3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl}imidazole-4-carbonyl)-c-hydroxycarbonimidoyl]propanoic acid
1,3,6,7-tetrahydroxy-2-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
1,3,6,7-tetrahydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
5,15,16-trihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docos-6-ene-2,8,12,18-tetrone
2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-8-yl]-3,4-dihydroxybenzoic acid
C22H14O10 (438.05869440000004)